CDER Plans Batch of Social Media, Biosimilars Guidance Docs in 2014

Drug Industry Daily
A A
CDER plans to issue highly anticipated guidance in 2014 that addresses social media usage for pharma marketing and the specifics about its biosimilars approval pathway.

To View This Article:

Login

Subscribe To Drug Industry Daily